{"date":"2025-04-25","count":23,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2025-04-25-2139-2wixgj","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:39:53","subject":"代子公司瑞華藥業(香港)有限公司公告董事解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:39，「代子公司瑞華藥業(香港)有限公司公告董事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-25-2135-6487ic","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:35:24","subject":"公告本公司董事會通過現金增資發行新股(變更資金用途)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:35，「公告本公司董事會通過現金增資發行新股(變更資金用途)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-25-2134-1iunxtj","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:34:59","subject":"代重要子公司迪瑞藥業(成都)有限公司公告董事解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:34，「代重要子公司迪瑞藥業(成都)有限公司公告董事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-25-2134-5tjt7q","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:34:36","subject":"代重要子公司Polaris Pharmaceuticals Inc.公告董事解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:34，「代重要子公司Polaris Pharmaceuticals Inc.公告董事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-25-2134-hcrns5","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:34:16","subject":"代重要子公司DesigneRx Pharmaceuticals, Inc.公告董事解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:34，「代重要子公司DesigneRx Pharmaceuticals, Inc.公告董事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-04-25-2132-fkzy5x","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"21:32:16","subject":"公告本公司訴訟及非訴訟代理人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-04-25 21:32，「公告本公司訴訟及非訴訟代理人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-04-25-2021-1qfg4x3","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"20:21:19","subject":"公告本公司114年第一季合併財務報告董事會預計召開日期為114年5月5日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-04-25 20:21，「公告本公司114年第一季合併財務報告董事會預計召開日期為114年5月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-04-25-2020-oh6ex5","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"20:20:19","subject":"公告本公司114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-04-25 20:20，「公告本公司114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-04-25-1916-1xhekbq","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"19:16:32","subject":"本公司授權夥伴Accord Healthcare向加拿大衛生部提交前列腺癌新劑型新藥CAMCEVI 3個月劑型新藥上市申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-04-25 19:16，「本公司授權夥伴Accord Healthcare向加拿大衛生部提交前列腺癌新劑型新藥CAMCEVI 3個月劑型新藥上市申」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-04-25-1815-l7qirp","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"18:15:35","subject":"公告本公司會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-04-25 18:15，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-04-25-1809-1pjoxx5","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"18:09:31","subject":"公告本公司114年第一季合併財務報告董事會預計召開日期為114年05月05日","clause":"第31款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-04-25 18:09，「公告本公司114年第一季合併財務報告董事會預計召開日期為114年05月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1745-bqcdn9","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:45:56","subject":"公告本公司第二屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:45，「公告本公司第二屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1745-k1qdeo","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:45:41","subject":"公告本公司第二屆審計委員會委員名單","clause":"第6款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:45，「公告本公司第二屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1745-1n1y3kt","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:45:18","subject":"公告本公司董事長續任","clause":"第6款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:45，「公告本公司董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1744-10qtgeu","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:44:50","subject":"公告本公司114年股東常會通過解除新任董事(含獨立董事)競業禁止之限制案","clause":"第22款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:44，「公告本公司114年股東常會通過解除新任董事(含獨立董事)競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1744-1b5u837","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:44:26","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)暨董事變動達三分之一","clause":"第6款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:44，「公告本公司114年股東常會全面改選董事(含獨立董事)暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-04-25-1743-ds864w","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-25","time":"17:43:33","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-04-25 17:43，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-04-25-1539-qkw3o","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"15:39:22","subject":"公告本公司114年第一季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-04-25 15:39，「公告本公司114年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-04-25-1531-1p08ssn","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"15:31:50","subject":"代子公司欣德芮股份有限公司公告租地委建廠房工程","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-04-25 15:31，「代子公司欣德芮股份有限公司公告租地委建廠房工程」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-04-25-1527-zptv0f","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"15:27:47","subject":"代重要子公司欣德芮股份有限公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-04-25 15:27，「代重要子公司欣德芮股份有限公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-04-25-1509-m71431","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"15:09:29","subject":"本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-04-25 15:09，「本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-04-25-1410-1gdx0mi","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-04-25","time":"14:10:32","subject":"公告114年第一季財務報告董事會召開日期為114年5月5日","clause":"第31款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-04-25 14:10，「公告114年第一季財務報告董事會召開日期為114年5月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-04-25-1334-1knbwua","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-04-25","time":"13:34:32","subject":"公告本公司114年第1季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-04-25","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-04-25 13:34，「公告本公司114年第1季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}